Revolution Lighting (RVLT) Prices 8M Common Offering at $1.25/Share Nov 25, 2014 07:59AM
Trina Solar (TSL) Investors are Seeking More Visibility - Roth Capital Nov 25, 2014 06:51AM
Revolution Lighting (RVLT) Announces Common Stock Offering Nov 24, 2014 04:20PM's Hot Lunchtime Reads 11/20: (LB) (AMZN) (REGN) (GS) (FB) Nov 20, 2014 12:17PM
Regeneron's (REGN) Dupilumab Receives FDA Breakthrough Designation; Roth Capital Comments Nov 20, 2014 10:46AM
View Older Stories

Nov 20, 2014 08:55AM Roth Updates Model on Trina Solar (TSL) Following Oct. Capital Raise; Affirms 'Buy' Rating
Nov 20, 2014 06:36AM Roth Cuts PT on RGS Energy (RGSE) to 80c Following Q3 Miss, Lack of Guidance
Nov 19, 2014 11:02AM Roth Comments on Regeneron (REGN) Following ODYSSEY Update at AHA (SNY)
Nov 19, 2014 09:55AM Roth is Buyer of JA Solar (JASO) Following Q3 Results; Affirms 'Buy' Rating
Nov 18, 2014 12:26PM Significant Partnership Could be in Store for Can-Fite (CANF) - Roth
Nov 18, 2014 09:28AM Roth Capital Starts New Gold (NGD) at Neutral
Nov 18, 2014 08:22AM Roth Capital Positive on Galena (GALE) Following Quick Enrollment of GALE-401 Phase 2
Nov 18, 2014 06:59AM Roth Capital Comments on Keryx (KERX) Following KOL Panel; Affirms 'Buy' Rating
Nov 17, 2014 10:54AM Notable Analyst Rating Changes 11/17: (MTG) (PSX) (CHK) Upgraded; (NOK) (ODP) (WTSL) Downgraded
Nov 17, 2014 09:42AM Pre-Open Stock Movers 11/17: (CLDX) (BHI) (AGN) Higher; (DWA) (GSAT) (HAL) Lower (more...)
Nov 17, 2014 08:46AM Roth Capital Lifts PT on Celldex (CLDX) to $43 Following Phase 2 ReACT Presentation
Nov 17, 2014 06:39AM Roth Capital Downgrades Hecla Mining (HL) to Neutral
Nov 14, 2014 11:49AM Roth Remains Positive on ImmunoCellular (IMUC) Following ICT-107 Phase 2 Presentation at SNO
Nov 13, 2014 08:55AM Canadian Solar's (CSIQ) Margin Guidance Spooks Investors, Buy Industry Position Remains Strong - Roth
Nov 13, 2014 07:57AM Roth Cuts PT on Plug Power (PLUG) to $4 Following 'Largely Disappointing' Q3 Report
Nov 13, 2014 07:57AM Roth Cuts PT on Plug Power (PLUG) to $4 Following 'Largely Disappointing' Q3 Report
Nov 12, 2014 11:37AM Roth Trims Price Target on Concert (CNCE) to $21; CTP-354 Phase II Delayed on Toxicity Signal
Nov 12, 2014 08:25AM Roth Capital Upgrades Dendreon (DNDN) to Neutral
Nov 11, 2014 12:47PM Roth Comments on Galena (GALE) Following Initiation of Herceptin Combo Trial
Nov 11, 2014 11:31AM Roth Positive on TG Therapeutics (TGTX) Following Q3 Results; Expects Strong ASH Showing
Nov 11, 2014 10:08AM The Joint Corp (JYNT) IPO Opens Slightly Higher
Nov 11, 2014 09:12AM Roth Affirms Sunesis (SNSS) at 'Neutral'; ASH Presentations May Help Clear Cloudy Outlook
Nov 11, 2014 07:50AM Sage (SAGE) SRSE Data is Positive for Ligand Pharma (LGND) - Roth
Nov 11, 2014 07:13AM Roth Capital Downgrades Planar Systems (PLNR) to Neutral
Nov 11, 2014 06:58AM Roth Capital Upgrades ICU Medical (ICUI) to Buy
Nov 10, 2014 02:34PM Roth Affirms Curis (CRIS) at 'Buy' Following Q3 Report, Update; Pipeline Progress is Encouraging
Nov 10, 2014 12:14PM's Hot Lunchtime Reads 11/10: (TWTR) (HIMX) (SVU) (AGU)
Nov 10, 2014 11:30AM Roth Capital 'Encouraged' by PoC Data from Celldex's (CLDX) Varlilumab Phase 1
Nov 10, 2014 11:01AM Roth Capital Trims PT on Clean Diesel Technologies (CDTI) to $3.50 Following Mixed Q3 Results
Nov 10, 2014 10:21AM Roth Capital Slashes PT on Dendreon (DNDN) to 15c; Sale Unlikely Following Ch. 11 Filing
Nov 7, 2014 09:27AM CTI BioPharma (CTIC) Prices $35M Offering of Convertible Preferred Stock
Nov 7, 2014 06:50AM Roth Capital Positive on TG Therapeutics (TGTX) Following Publication of ASH Abstracts
Nov 6, 2014 03:44PM SolarCity (SCTY) Still 'Buy'-Rated at Roth; Would Likely Withstand Peer Pricing Pressure
Nov 6, 2014 02:09PM Roth Capital Positive on Synta (SNTA) Following Q3 Results; Focus Remains on Ganetespib Phase III GALAXY-2
Nov 6, 2014 11:27AM Roth Capital Remains Positive on Keryx (KERX) Following Q3 Results, Update
Nov 5, 2014 11:40AM Synta's (SNTA) Ganetespib Could See Extra Exclusivity Following FDA Meeting - Roth
Nov 4, 2014 11:56AM Roth Cap Remains Positive on Galena Biopharma (GALE) Following Q3 Results, Update
Nov 4, 2014 08:57AM Roth Capital Starts Ballard Power Systems (BLDP) at Buy
Nov 3, 2014 11:44AM Roth 'Encouraged' by Initial BL-8040 Safety, Pharmacodynamic Data; Maintains BioLineRx (BLRX) at 'Buy'
Nov 3, 2014 07:21AM NeuroDerm Announces Launch of Initial Public Offering
Nov 3, 2014 07:00AM Roth Capital Starts Hyperion Therapeutics (HPTX) at Buy
Nov 3, 2014 06:57AM Roth Capital Downgrades GP Strategies (GPX) to Neutral
Oct 31, 2014 10:49AM Notable Analyst Rating Changes 10/31: (AXTI) (MPW) (ACHC) Upgraded; (ARR) (AVP) (TASR) Downgraded
Oct 31, 2014 09:24AM UPDATE: Roth Capital Starts Daqo New Energy (DQ) at Buy
Oct 30, 2014 02:35PM Peregrine's (PPHM) Phase Ib IST of Bavituximab Important Progress in Development as NSCLC Treatment - Roth
Oct 30, 2014 07:30AM LiquidSpace Raises $14 Million In Additional Funding
Oct 30, 2014 07:30AM LiquidSpace Raises $14 Million In Additional Funding
Oct 29, 2014 05:30PM ROTH Capital Partners Announces Appointment of John Chambers as Vice-Chairman
Oct 29, 2014 02:10PM Roth Affirms GenVec (GNVC) at 'Buy'; Novartis Partnership is Entering 'Prime Time'
Oct 29, 2014 12:24PM Roth Capital Maintains Synta Pharma (SNTA) at 'Buy; Has Initial Meeting with CEO Whitaker
View Older Stories